Although the precise function of utrophin at the postsynaptic membrane
of the neuromuscular junction still remains unclear, despite recent g
enetic 'knockout' experiments((1,2)), a separate study in a transgenic
mouse model system for Duchenne muscular dystrophy (DMD) has nonethel
ess shown that overexpression of utrophin into extrasynaptic regions o
f muscle fibers can functionally compensate for the lack of dystrophin
and alleviate the muscle pathology((3)). In this context, the next st
ep is to identify the mechanisms presiding over expression of utrophin
at the neuromuscular synapse in attempts to induce its expression thr
oughout DMD muscle fibers. In fact,additional studies have shown that
an important DNA element contained with the utrophin promoter may conf
er synapse-specific expression to the utrophin gene((4,5)). Identifica
tion of the events culminating in the transactivation of the utrophin
gene within synaptic myonuclei should provide important cues for the d
evelopment of an effective therapeutic strategy for DMD.